+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global MRSA Testing Market 2023-2027

  • PDF Icon

    Report

  • 162 Pages
  • February 2023
  • Region: Global
  • TechNavio
  • ID: 5305719
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The MRSA testing market is forecasted to grow by $682.12 mn during 2022-2027, accelerating at a CAGR of 12.13% during the forecast period. The report on the MRSA testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of staphylococcal infections, introduction of new MRSA diagnostic tests, and increased adoption of automation and system integration in healthcare.

The MRSA testing market is segmented as below:

By End-user

  • Hospitals and diagnostic laboratories
  • Academic and research institutes

By Type

  • Molecular diagnostics
  • Immunodiagnostics

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increasing demand for infection control committees in hospitals as one of the prime reasons driving the MRSA testing market growth during the next few years. Also, rise in use of MRSA quick tests using lab-on-chip technology in hospital settings and the emergence of PCR-free electrochemical POC testing for rapid clinical detection of MRSA will lead to sizable demand in the market.

The report on the MRSA testing market covers the following areas:

  • MRSA testing market sizing
  • MRSA testing market forecast
  • MRSA testing market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading MRSA testing market vendors that include 3M Co., Abbott Laboratories, ALIFAX Srl, Arlington Scientific Inc., Becton Dickinson and Co., bioMerieux SA, Bio Rad Laboratories Inc., Bruker Corp., Creative Diagnostics, Danaher Corp., DiaSorin Spa, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., GENSPEED Biotech GmbH, OpGen Inc., Puritan Medical Products Co., R Biopharm AG, Sekisui Diagnostics LLC, Uniogen Oy, and ZeptoMetrix LLC. Also, the MRSA testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global MRSA testing market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global MRSA testing market 2017 - 2021 ($ million)
4.2 End-user Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user
6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Hospitals and diagnostic laboratories - Market size and forecast 2022-2027
Exhibit 34: Chart on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
6.4 Academic and research institutes - Market size and forecast 2022-2027
Exhibit 38: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by End-user
Exhibit 42: Market opportunity by End-user ($ million)

7 Market Segmentation by Type
7.1 Market segments
Exhibit 43: Chart on Type - Market share 2022-2027 (%)
Exhibit 44: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 45: Chart on Comparison by Type
Exhibit 46: Data Table on Comparison by Type
7.3 Molecular diagnostics - Market size and forecast 2022-2027
Exhibit 47: Chart on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
7.4 Immunodiagnostics - Market size and forecast 2022-2027
Exhibit 51: Chart on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Type
Exhibit 55: Market opportunity by Type ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 57: Chart on Market share by geography 2022-2027 (%)
Exhibit 58: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 59: Chart on Geographic comparison
Exhibit 60: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 77: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 81: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Japan - Market size and forecast 2022-2027
Exhibit 89: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 97: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 98: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 100: Overview on factors of disruption
11.4 Industry risks
Exhibit 101: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 102: Vendors covered
12.2 Market positioning of vendors
Exhibit 103: Matrix on vendor position and classification
12.3 3M Co.
Exhibit 104: 3M Co. - Overview
Exhibit 105: 3M Co. - Business segments
Exhibit 106: 3M Co. - Key offerings
Exhibit 107: 3M Co. - Segment focus
12.4 Abbott Laboratories
Exhibit 108: Abbott Laboratories - Overview
Exhibit 109: Abbott Laboratories - Business segments
Exhibit 110: Abbott Laboratories - Key news
Exhibit 111: Abbott Laboratories - Key offerings
Exhibit 112: Abbott Laboratories - Segment focus
12.5 Arlington Scientific Inc.
Exhibit 113: Arlington Scientific Inc. - Overview
Exhibit 114: Arlington Scientific Inc. - Product / Service
Exhibit 115: Arlington Scientific Inc. - Key offerings
12.6 Becton Dickinson and Co.
Exhibit 116: Becton Dickinson and Co. - Overview
Exhibit 117: Becton Dickinson and Co. - Business segments
Exhibit 118: Becton Dickinson and Co. - Key news
Exhibit 119: Becton Dickinson and Co. - Key offerings
Exhibit 120: Becton Dickinson and Co. - Segment focus
12.7 bioMerieux SA
Exhibit 121: bioMerieux SA - Overview
Exhibit 122: bioMerieux SA - Product / Service
Exhibit 123: bioMerieux SA - Key offerings
12.8 Bio Rad Laboratories Inc.
Exhibit 124: Bio Rad Laboratories Inc. - Overview
Exhibit 125: Bio Rad Laboratories Inc. - Business segments
Exhibit 126: Bio Rad Laboratories Inc. - Key news
Exhibit 127: Bio Rad Laboratories Inc. - Key offerings
Exhibit 128: Bio Rad Laboratories Inc. - Segment focus
12.9 Bruker Corp.
Exhibit 129: Bruker Corp. - Overview
Exhibit 130: Bruker Corp. - Business segments
Exhibit 131: Bruker Corp. - Key news
Exhibit 132: Bruker Corp. - Key offerings
Exhibit 133: Bruker Corp. - Segment focus
12.10 Danaher Corp.
Exhibit 134: Danaher Corp. - Overview
Exhibit 135: Danaher Corp. - Business segments
Exhibit 136: Danaher Corp. - Key news
Exhibit 137: Danaher Corp. - Key offerings
Exhibit 138: Danaher Corp. - Segment focus
12.11 DiaSorin Spa
Exhibit 139: DiaSorin Spa - Overview
Exhibit 140: DiaSorin Spa - Business segments
Exhibit 141: DiaSorin Spa - Key offerings
Exhibit 142: DiaSorin Spa - Segment focus
12.12 Eurofins Scientific SE
Exhibit 143: Eurofins Scientific SE - Overview
Exhibit 144: Eurofins Scientific SE - Business segments
Exhibit 145: Eurofins Scientific SE - Key news
Exhibit 146: Eurofins Scientific SE - Key offerings
Exhibit 147: Eurofins Scientific SE - Segment focus
12.13 F. Hoffmann La Roche Ltd.
Exhibit 148: F. Hoffmann La Roche Ltd. - Overview
Exhibit 149: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 150: F. Hoffmann La Roche Ltd. - Key news
Exhibit 151: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 152: F. Hoffmann La Roche Ltd. - Segment focus
12.14 GENSPEED Biotech GmbH
Exhibit 153: GENSPEED Biotech GmbH - Overview
Exhibit 154: GENSPEED Biotech GmbH - Product / Service
Exhibit 155: GENSPEED Biotech GmbH - Key offerings
12.15 OpGen Inc.
Exhibit 156: OpGen Inc. - Overview
Exhibit 157: OpGen Inc. - Product / Service
Exhibit 158: OpGen Inc. - Key offerings
12.16 Puritan Medical Products Co.
Exhibit 159: Puritan Medical Products Co. - Overview
Exhibit 160: Puritan Medical Products Co. - Product / Service
Exhibit 161: Puritan Medical Products Co. - Key offerings
12.17 Uniogen Oy
Exhibit 162: Uniogen Oy - Overview
Exhibit 163: Uniogen Oy - Product / Service
Exhibit 164: Uniogen Oy - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 165: Inclusions checklist
Exhibit 166: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 167: Currency conversion rates for US$
13.4 Research methodology
Exhibit 168: Research methodology
Exhibit 169: Validation techniques employed for market sizing
Exhibit 170: Information sources
13.5 List of abbreviations
Exhibit 171: List of abbreviations

List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global MRSA testing market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on End-user - Market share 2022-2027 (%)
Exhibits 31: Data Table on End-user - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by End-user
Exhibits 33: Data Table on Comparison by End-user
Exhibits 34: Chart on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by End-user ($ million)
Exhibits 43: Chart on Type - Market share 2022-2027 (%)
Exhibits 44: Data Table on Type - Market share 2022-2027 (%)
Exhibits 45: Chart on Comparison by Type
Exhibits 46: Data Table on Comparison by Type
Exhibits 47: Chart on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Data Table on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Chart on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
Exhibits 50: Data Table on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
Exhibits 51: Chart on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits 52: Data Table on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Chart on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
Exhibits 54: Data Table on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
Exhibits 55: Market opportunity by Type ($ million)
Exhibits 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 57: Chart on Market share by geography 2022-2027 (%)
Exhibits 58: Data Table on Market share by geography 2022-2027 (%)
Exhibits 59: Chart on Geographic comparison
Exhibits 60: Data Table on Geographic comparison
Exhibits 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 63: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 77: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 79: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 80: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 81: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 82: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 83: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 84: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 87: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 88: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 89: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 90: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 91: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 92: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 97: Market opportunity by geography ($ million)
Exhibits 98: Impact of drivers and challenges in 2022 and 2027
Exhibits 99: Overview on Criticality of inputs and Factors of differentiation
Exhibits 100: Overview on factors of disruption
Exhibits 101: Impact of key risks on business
Exhibits 102: Vendors covered
Exhibits 103: Matrix on vendor position and classification
Exhibits 104: 3M Co. - Overview
Exhibits 105: 3M Co. - Business segments
Exhibits 106: 3M Co. - Key offerings
Exhibits 107: 3M Co. - Segment focus
Exhibits 108: Abbott Laboratories - Overview
Exhibits 109: Abbott Laboratories - Business segments
Exhibits 110: Abbott Laboratories - Key news
Exhibits 111: Abbott Laboratories - Key offerings
Exhibits 112: Abbott Laboratories - Segment focus
Exhibits 113: Arlington Scientific Inc. - Overview
Exhibits 114: Arlington Scientific Inc. - Product / Service
Exhibits 115: Arlington Scientific Inc. - Key offerings
Exhibits 116: Becton Dickinson and Co. - Overview
Exhibits 117: Becton Dickinson and Co. - Business segments
Exhibits 118: Becton Dickinson and Co. - Key news
Exhibits 119: Becton Dickinson and Co. - Key offerings
Exhibits 120: Becton Dickinson and Co. - Segment focus
Exhibits 121: bioMerieux SA - Overview
Exhibits 122: bioMerieux SA - Product / Service
Exhibits 123: bioMerieux SA - Key offerings
Exhibits 124: Bio Rad Laboratories Inc. - Overview
Exhibits 125: Bio Rad Laboratories Inc. - Business segments
Exhibits 126: Bio Rad Laboratories Inc. - Key news
Exhibits 127: Bio Rad Laboratories Inc. - Key offerings
Exhibits 128: Bio Rad Laboratories Inc. - Segment focus
Exhibits 129: Bruker Corp. - Overview
Exhibits 130: Bruker Corp. - Business segments
Exhibits 131: Bruker Corp. - Key news
Exhibits 132: Bruker Corp. - Key offerings
Exhibits 133: Bruker Corp. - Segment focus
Exhibits 134: Danaher Corp. - Overview
Exhibits 135: Danaher Corp. - Business segments
Exhibits 136: Danaher Corp. - Key news
Exhibits 137: Danaher Corp. - Key offerings
Exhibits 138: Danaher Corp. - Segment focus
Exhibits 139: DiaSorin Spa - Overview
Exhibits 140: DiaSorin Spa - Business segments
Exhibits 141: DiaSorin Spa - Key offerings
Exhibits 142: DiaSorin Spa - Segment focus
Exhibits 143: Eurofins Scientific SE - Overview
Exhibits 144: Eurofins Scientific SE - Business segments
Exhibits 145: Eurofins Scientific SE - Key news
Exhibits 146: Eurofins Scientific SE - Key offerings
Exhibits 147: Eurofins Scientific SE - Segment focus
Exhibits 148: F. Hoffmann La Roche Ltd. - Overview
Exhibits 149: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 150: F. Hoffmann La Roche Ltd. - Key news
Exhibits 151: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 152: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 153: GENSPEED Biotech GmbH - Overview
Exhibits 154: GENSPEED Biotech GmbH - Product / Service
Exhibits 155: GENSPEED Biotech GmbH - Key offerings
Exhibits 156: OpGen Inc. - Overview
Exhibits 157: OpGen Inc. - Product / Service
Exhibits 158: OpGen Inc. - Key offerings
Exhibits 159: Puritan Medical Products Co. - Overview
Exhibits 160: Puritan Medical Products Co. - Product / Service
Exhibits 161: Puritan Medical Products Co. - Key offerings
Exhibits 162: Uniogen Oy - Overview
Exhibits 163: Uniogen Oy - Product / Service
Exhibits 164: Uniogen Oy - Key offerings
Exhibits 165: Inclusions checklist
Exhibits 166: Exclusions checklist
Exhibits 167: Currency conversion rates for US$
Exhibits 168: Research methodology
Exhibits 169: Validation techniques employed for market sizing
Exhibits 170: Information sources
Exhibits 171: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global MRSA testing market: 3M Co., Abbott Laboratories, ALIFAX Srl, Arlington Scientific Inc., Becton Dickinson and Co., bioMerieux SA, Bio Rad Laboratories Inc., Bruker Corp., Creative Diagnostics, Danaher Corp., DiaSorin Spa, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., GENSPEED Biotech GmbH, OpGen Inc., Puritan Medical Products Co., R Biopharm AG, Sekisui Diagnostics LLC, Uniogen Oy, and ZeptoMetrix LLC.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increasing demand for infection control committees in hospitals.`

According to the report, one of the major drivers for this market is the increasing incidence of staphylococcal infections.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 3M Co.
  • Abbott Laboratories
  • ALIFAX Srl
  • Arlington Scientific Inc.
  • Becton Dickinson and Co.
  • bioMerieux SA
  • Bio Rad Laboratories Inc.
  • Bruker Corp.
  • Creative Diagnostics
  • Danaher Corp.
  • DiaSorin Spa
  • Eurofins Scientific SE
  • F. Hoffmann La Roche Ltd.
  • GENSPEED Biotech GmbH
  • OpGen Inc.
  • Puritan Medical Products Co.
  • R Biopharm AG
  • Sekisui Diagnostics LLC
  • Uniogen Oy
  • ZeptoMetrix LLC